Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae
- PMID: 30385204
- DOI: 10.1016/j.ijmm.2018.10.008
Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae
Abstract
Objectives: Biofilm production in extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae provides a favourable environment for the exchange of antibiotic-resistance genes and could facilitate widespread dissemination. We aimed to assess biofilm development in ESBL-producing E. coli and K. pneumoniae isolates and determine how development relates to microbiological characteristics and clinical outcomes.
Methods: 147 ESBL-producing E. coli and 82 K. pneumoniae were genetically characterized. Biofilm formation was measured at 1.5, 4, 6, and 24 h during culture in blood heart infusion using a microbead immobilization assay (BioFilm Ring test®). Results were given as biofilm formation index (BFI) with lower values indicating increased presence of biofilm (range = 0-21).
Results: In total, 57.1% of strains were strong producers of biofilm (BFI < 2), whereas 13.4% lacked biofilm production (BFI > 18). Standard biofilm production (BFI < 7) was common in E. coli isolates (61.9%). For E. coli, biofilm production was less frequently observed in ST131 clones (p = 0.03) but more frequently in strains harbouring toxin (p = 0.008) or adhesin (p = 0.008) virulence factor genes. Despite almost all K. pneumoniae having standard biofilm production (90.2%), there was a 2.4-times higher odds of observing biofilm in ST29/147/323 versus other ST-types (p = 0.13). Patients with standard biofilm producing isolates were not at increased risk of transfer to intensive-care (odds-ratio=2.80, 95%CI=0.59-13.21) or death within 12-months (odds-ratio=1.61, 95%CI=0.75-3.43).
Conclusion: In these ESBL-producing strains, biofilm production is linked to certain virulence factors in E. coli and is common in K. pneumoniae. Further exploration of whether biofilm production increases dissemination and risk of severe clinical outcomes is needed in larger collections of isolates.
Keywords: Biofilm kinetics; Biofilm production; ESBL-producing enterobacteriaceae; Escherichia coli; Klebsiella pneumoniae.
Copyright © 2018 Elsevier GmbH. All rights reserved.
Similar articles
-
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.Diagn Microbiol Infect Dis. 2017 Jan;87(1):45-48. doi: 10.1016/j.diagmicrobio.2016.10.007. Epub 2016 Oct 7. Diagn Microbiol Infect Dis. 2017. PMID: 27773544
-
Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.Med Mal Infect. 2013 Aug;43(8):331-6. doi: 10.1016/j.medmal.2013.06.001. Epub 2013 Jul 19. Med Mal Infect. 2013. PMID: 23876202
-
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.J Antimicrob Chemother. 2013 May;68 Suppl 1:i57-65. doi: 10.1093/jac/dkt027. J Antimicrob Chemother. 2013. PMID: 23587779
-
Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.Infect Genet Evol. 2011 Oct;11(7):1499-504. doi: 10.1016/j.meegid.2011.06.001. Epub 2011 Jun 12. Infect Genet Evol. 2011. PMID: 21689785 Review.
-
Biofilm Formation Status in ESBL-Producing Bacteria Recovered from Clinical Specimens of Patients: A Systematic Review and Meta-Analysis.Infect Disord Drug Targets. 2023;23(2):e200922208987. doi: 10.2174/1871526522666220920141631. Infect Disord Drug Targets. 2023. PMID: 36125823
Cited by
-
Pathogenomics and clinical recurrence influence biofilm capacity of Escherichia coli isolated from canine urinary tract infections.PLoS One. 2022 Aug 25;17(8):e0270461. doi: 10.1371/journal.pone.0270461. eCollection 2022. PLoS One. 2022. PMID: 36006972 Free PMC article.
-
Morphological and adhesive properties of Klebsiella pneumoniae biofilms.Vet World. 2020 Jan;13(1):197-200. doi: 10.14202/vetworld.2020.197-200. Epub 2020 Jan 28. Vet World. 2020. PMID: 32158172 Free PMC article.
-
Probiotic lactic acid bacteria as a means of preventing in vitro urinary catheter colonization and biofilm formation.J Egypt Public Health Assoc. 2023 Jan 3;97(1):30. doi: 10.1186/s42506-022-00124-2. J Egypt Public Health Assoc. 2023. PMID: 36593358 Free PMC article.
-
Comparison of virulence factors between ESBL and non-ESBL producing Klebsiella pneumoniae isolates.Iran J Microbiol. 2024 Feb;16(1):39-48. doi: 10.18502/ijm.v16i1.14869. Iran J Microbiol. 2024. PMID: 38682061 Free PMC article.
-
Study on the inhibition activity and mechanism of Tanreqing against Klebsiella pneumoniae biofilm formation in vitro and in vivo.Front Cell Infect Microbiol. 2024 Apr 4;14:1368450. doi: 10.3389/fcimb.2024.1368450. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38638833 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical